{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:17:21Z","timestamp":1789690641970,"version":"4.0.1"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Laminin 332 is a heterotrimeric structural protein of the basal membrane zone (BMZ) of the skin and adjacent mucosal tissues. The importance of laminin 332 for the structural integrity of the BMZ is demonstrated by mutations in any of the three genes encoding for its three chains causing variants of junctional epidermolysis bullosa. Autoimmunity against laminin 332 is observed in mucous membrane pemphigoid (MMP) and in the rare patients with orf-induced pemphigoid. MMP is an autoimmune blistering disease with predominant mucosal manifestations and autoantibodies against the BMZ of the skin and orifice-close mucous membranes. The main autoantigens of MMP are type XVII collagen (BP180) and laminin 332 targeted in about 80% and 10-20% of patients, respectively. An increasing number of studies has highlighted the association of anti-laminin 332 MMP and malignancies that can be revealed in about a quarter of these patients. This data has led to the recommendation of current guidelines to assay for anti-laminin 332 reactivity in all MMP patients. The present review focuses on anti-laminin 332 MMP describing clinical features, its pathophysiology, and detection of serum anti-laminin 332 IgG. In addition, the available data about the occurrence of malignancies in anti-laminin 332 MMP, the underlying tumor entities, and its biology are detailed.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1250115","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T22:59:55Z","timestamp":1691708395000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Autoimmunity against laminin 332"],"prefix":"10.3389","volume":"14","author":[{"given":"Sabrina","family":"Patzelt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4161\/cam.22826","article-title":"The laminin family","volume":"7","author":"Aumailley","year":"2013","journal-title":"Cell Adhesion Migration"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18921","article-title":"Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility","volume":"183","author":"Has","year":"2020","journal-title":"Br J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116033","article-title":"Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease","volume":"90","author":"Domloge-Hultsch","year":"1992","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.0290","article-title":"Clinical and serological characterization of orf-induced immunobullous disease","volume":"158","author":"Yilmaz","year":"2022","journal-title":"JAMA Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.07.036","article-title":"Subepidermal blistering disease with autoantibodies to both the P200 autoantigen and the Alpha3 chain of laminin 5","volume":"52","author":"Shimanovich","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.10065.x","article-title":"Childhood subepidermal blistering disease with autoantibodies to type vii collagen and laminin-332","volume":"164","author":"Lin","year":"2011","journal-title":"Br J Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.5691","article-title":"Three cases of linear Iga\/Igg bullous dermatosis showing iga and igg reactivity with multiple antigens, particularly laminin-332","volume":"149","author":"Sakaguchi","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14169","article-title":"Case of epidermolysis bullosa acquisita with concomitant anti-Laminin-332 antibodies","volume":"45","author":"Nishida","year":"2018","journal-title":"J Dermatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.07.076","article-title":"Serologic characterization of anti-P200 pemphigoid: Epitope spreading as a common phenomenon","volume":"84","author":"Holtsche","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16008","article-title":"Case of pemphigoid with antibodies to Bp180 c-terminal domain and Alpha3 subunit of laminin-332 associated with chronic graft-Versus-Host disease","volume":"48","author":"Kawashima","year":"2021","journal-title":"J Dermatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2005.05.006","article-title":"A simplified laminin nomenclature","volume":"24","author":"Aumailley","year":"2005","journal-title":"Matrix Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13446","article-title":"Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases","volume":"26","author":"Goletz","year":"2017","journal-title":"Exp Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00491.x","article-title":"Nc1 domain of type vii collagen binds to the Beta3 chain of laminin 5 Via a unique subdomain within the fibronectin-like repeats","volume":"112","author":"Chen","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2010.10.005","article-title":"Type xvii collagen (Bp180) can function as a cell-matrix adhesion molecule Via binding to laminin 332","volume":"30","author":"Van den Bergh","year":"2011","journal-title":"Matrix Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.300061","article-title":"Cell surface proteoglycans syndecan-1 and -4 bind overlapping but distinct sites in laminin Alpha3 Lg45 protein domain","volume":"287","author":"Carulli","year":"2012","journal-title":"J Biol Chem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2005.12.001","article-title":"Ligand-binding specificities of laminin-binding integrins: A comprehensive survey of laminin-integrin interactions using recombinant Alpha3beta1, Alpha6beta1, Alpha7beta1 and Alpha6beta4 integrins","volume":"25","author":"Nishiuchi","year":"2006","journal-title":"Matrix Biol"},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","article-title":"Autoimmune subepidermal bullous diseases of the skin and mucosae: Clinical features, diagnosis, and management","volume":"54","author":"Amber","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2021.0136","article-title":"Bullous autoimmune dermatoses","volume":"118","author":"Beek","year":"2021","journal-title":"Dtsch Arztebl Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17397","article-title":"European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the european academy of dermatology and venereology - part i","volume":"35","author":"Rashid","year":"2021","journal-title":"J Eur Acad Dermatol Venereol: JEADV"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103036","article-title":"Mucous membrane pemphigoid","volume":"21","author":"Du","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04471.x","article-title":"Cicatricial pemphigoid: Iga and igg autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180","volume":"145","author":"Schmidt","year":"2001","journal-title":"Br J Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17395","article-title":"European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the european academy of dermatology and venereology - part II","volume":"35","author":"Schmidt","year":"2021","journal-title":"J Eur Acad Dermatol Venereol: JEADV"},{"key":"B25","article-title":"The role of antibody to human Beta4 integrin in conjunctival basement membrane separation: Possible in vitro model for ocular cicatricial pemphigoid","volume":"40","author":"Chan","year":"1999","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.3.1968","article-title":"Identification of an epitope within human integrin alpha 6 subunit for the binding of autoantibody and its role in basement membrane separation in oral pemphigoid","volume":"176","author":"Rashid","year":"2006","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2016.2772","article-title":"Integrin Beta4 is a major target antigen in pure ocular mucous membrane pemphigoid","volume":"26","author":"Li","year":"2016","journal-title":"Eur J Dermatol: EJD"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18617","article-title":"Anti-Beta4 integrin autoantibodies in patients with mucous membrane pemphigoid: A retrospective analysis from a tertiary centre in italy","volume":"37","author":"Maglie","year":"2023","journal-title":"J Eur Acad Dermatol Venereol: JEADV"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14905","article-title":"S2k guideline for the diagnosis and treatment of mucous membrane pemphigoid","volume":"20","author":"Hofmann","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"B30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three french regions. bullous diseases french study group","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2008.06976.x","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in lower franconia, germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.07.013","article-title":"Prevalence and age distribution of pemphigus and pemphigoid diseases in germany","volume":"136","author":"Hubner","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17107","article-title":"Incidence of pemphigoid diseases in northern germany in 2016 - first data from the schleswig-holstein registry of autoimmune bullous diseases","volume":"35","author":"van Beek","year":"2021","journal-title":"J Eur Acad Dermatol Venereol: JEADV"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2011.01.014","article-title":"[Mucous membrane pemphigoid. guidelines for the diagnosis and treatment. centres de reference des maladies bulleuses auto-immunes. societe francaise de dermatologie]","volume":"138","author":"Bedane","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-019-4387-7","article-title":"Epidermolysis bullosa acquisita","volume":"70","author":"Hofmann","year":"2019","journal-title":"Hautarzt"},{"key":"B36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1590\/abd1806-4841.2019940207","article-title":"Consensus on the treatment of autoimmune bullous dermatoses: Bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - brazilian society of dermatology","volume":"94","author":"Santi","year":"2019","journal-title":"Anais Brasileiros Dermatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15111","article-title":"Japanese guidelines for the management of pemphigoid (Including epidermolysis bullosa acquisita)","volume":"46","author":"Ujiie","year":"2019","journal-title":"J Dermatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17202","article-title":"A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid","volume":"180","author":"Goletz","year":"2019","journal-title":"Br J Dermatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13397","article-title":"A systematic review with pooled analysis of clinical presentation and immunodiagnostic testing in mucous membrane pemphigoid: Association of anti-Laminin-332 igg with oropharyngeal involvement and the usefulness of elisa","volume":"30","author":"Amber","year":"2016","journal-title":"J Eur Acad Dermatol Venereol: JEADV"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.771766","article-title":"The second study of clinical and immunological findings in anti-laminin 332-type mucous membrane pemphigoid examined at kurume university-diagnosis criteria suggested by summary of 133 cases","volume":"12","author":"Qian","year":"2021","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.4773","article-title":"Evaluation of site- and autoantigen-specific characteristics of mucous membrane pemphigoid","volume":"158","author":"van Beek","year":"2022","journal-title":"JAMA Dermatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1980.tb06550.x","article-title":"Epidermolysis bullosa acquisita. immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients","volume":"102","author":"Nieboer","year":"1980","journal-title":"Br J Dermatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12526124","article-title":"Epidermolysis bullosa acquisita: Ultrastructural and immunological studies","volume":"76","author":"Yaoita","year":"1981","journal-title":"J Invest Dermatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12461226","article-title":"Immunoelectron microscopy in subepidermal autoimmune bullous diseases: A prospective study of igg and C3 bound in vivo in 32 patients","volume":"89","author":"Prost","year":"1987","journal-title":"J Invest Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1994.01690120057008","article-title":"Antiepiligrin cicatricial pemphigoid. a subepithelial bullous disorder","volume":"130","author":"Domloge-Hultsch","year":"1994","journal-title":"Arch Dermatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/bjd.16138","article-title":"International bullous diseases group: Consensus on diagnostic criteria for epidermolysis bullosa acquisita","volume":"179","author":"Prost-Squarcioni","year":"2018","journal-title":"Br J Dermatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10474.x","article-title":"Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin-332 mucous membrane pemphigoid: Immunopathological findings and clinical experience in 10 dutch patients","volume":"165","author":"Terra","year":"2011","journal-title":"Br J Dermatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12323431","article-title":"Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5","volume":"105","author":"Kirtschig","year":"1995","journal-title":"J Invest Dermatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02502.x","article-title":"Antiepiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (Alpha3beta3gamma2)","volume":"139","author":"Lazarova","year":"1998","journal-title":"Br J Dermatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.06.004","article-title":"Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid","volume":"51","author":"Lazarova","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05316.x","article-title":"Human placental amnion is a novel substrate for detecting autoantibodies in autoimmune bullous diseases by immunoblotting","volume":"148","author":"Oyama","year":"2003","journal-title":"Br J Dermatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2001.5091","article-title":"Igg autoantibodies in patients with anti-epiligrin cicatricial pemphigoid recognize the g domain of the laminin 5 alpha-subunit","volume":"101","author":"Lazarova","year":"2001","journal-title":"Clin Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/s0923-1811(03)00158-0","article-title":"Usefulness of immunoblotting using purified laminin 5 in the diagnosis of anti-laminin 5 cicatricial pemphigoid","volume":"33","author":"Hisamatsu","year":"2003","journal-title":"J Dermatol Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/jop.12780","article-title":"The identification of autoantigens in mucous membrane pemphigoid using immortalized oral mucosal keratinocytes","volume":"48","author":"Kamaguchi","year":"2019","journal-title":"J Oral Pathol Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23646.x","article-title":"Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by elisa","volume":"124","author":"Bekou","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.1434","article-title":"Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid","volume":"149","author":"Bernard","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13023-018-0855-x","article-title":"Molecular diagnosis of anti-laminin 332 (Epiligrin) mucous membrane pemphigoid","volume":"13","author":"Chiorean","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.02.035","article-title":"Igg anti-Laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoid","volume":"58","author":"Lazarova","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18129","article-title":"Keratinocyte footprint assay discriminates antilaminin-332 pemphigoid from all other forms of pemphigoid diseases","volume":"182","author":"Giurdanella","year":"2020","journal-title":"Br J Dermatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.773720","article-title":"Comparison of two diagnostic assays for anti-laminin 332 mucous membrane pemphigoid","volume":"12","author":"Goletz","year":"2021","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.99","article-title":"Anti-epiligrin cicatricial pemphigoid and epidermolysis bullosa acquisita: Differentiation by use of indirect immunofluorescence microscopy","volume":"48","author":"Vodegel","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2011.07840.x","article-title":"Diagnostics of autoimmune bullous diseases in german dermatology departments","volume":"10","author":"van Beek","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.12.032","article-title":"Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita","volume":"68","author":"Komorowski","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.01.049","article-title":"Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the biochip technology","volume":"83","author":"van Beek","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15770","article-title":"Validation of the biochip test for the diagnosis of bullous pemphigoid, pemphigus vulgaris and pemphigus foliaceus","volume":"34","author":"Yang","year":"2020","journal-title":"J Eur Acad Dermatol Venereol: JEADV"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2021.4104","article-title":"Anti-laminin 332 antibody detection using biochip immunofluorescence microscopy in a real-life cohort of italian patients with mucous membrane pemphigoid","volume":"32","author":"Gasparini","year":"2022","journal-title":"Eur J Dermatol: EJD"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S359589","article-title":"A probing of the issue of detecting igg, Igg4 and iga antibodies to laminin 332 epitopes in mucous membrane pemphigoid: A clinical-laboratory experience of a single central european university dermatology department","volume":"15","author":"Gornowicz-Porowska","year":"2022","journal-title":"Clin Cosmetic Investigational Dermatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09508.x","article-title":"Circulating iga and ige autoantibodies in antilaminin-332 mucous membrane pemphigoid","volume":"162","author":"Natsuga","year":"2010","journal-title":"Br J Dermatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10776.x","article-title":"Mucous membrane pemphigoid with generalized blisters: Iga and igg autoantibodies target both laminin-332 and type xvii collagen","volume":"166","author":"Hayashi","year":"2012","journal-title":"Br J Dermatol"},{"key":"B70","article-title":"Immunobullous disorders","volume-title":"Rook\u2019s Textbook of Dermatology, part 3, chapter 50","author":"Schmidt","year":""},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1997.tb01118.x","article-title":"Anti-epiligrin (Laminin 5) cicatricial pemphigoid and lung carcinoma: Coincidence or association","volume":"137","author":"Gibson","year":"1997","journal-title":"Br J Dermatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.9.1091","article-title":"Antiepiligrin cicatricial pemphigoid: An underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases","volume":"135","author":"Leverkus","year":"1999","journal-title":"Arch Dermatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04971-0","article-title":"Anti-epiligrin cicatricial pemphigoid and relative risk for cancer","volume":"357","author":"Egan","year":"2001","journal-title":"Lancet"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2004.tb00497.x","article-title":"A case of anti-epiligrin cicatricial pemphigoid associated with lung carcinoma and severe laryngeal stenosis: Review of japanese cases and evaluation of risk for internal malignancy","volume":"31","author":"Matsushima","year":"2004","journal-title":"J Dermatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2013.12.402","article-title":"Diagnosis of oral mucous membrane pemphigoid by means of combined serologic testing","volume":"117","author":"Hayakawa","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20099","article-title":"Clinical and immunological findings in 55 patients with anti-laminin 332-type mucous membrane pemphigoid","volume":"185","author":"Li","year":"2021","journal-title":"Br J Dermatol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/biom12101461","article-title":"Anti-laminin 332-type mucous membrane pemphigoid","volume":"12","author":"Shi","year":"2022","journal-title":"Biomolecules"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1991.tb06077.x","article-title":"No association between cicatricial pemphigoid and malignant disease","volume":"125","author":"Nayar","year":"1991","journal-title":"Br J Dermatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2007.02463.x","article-title":"Relative risk for cancer in mucous membrane pemphigoid associated with antibodies to the Beta4 integrin subunit","volume":"32","author":"Letko","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0714.2006.00483.x","article-title":"Relationship between cancer and oral pemphigoid patients with antibodies to Alpha6-integrin","volume":"36","author":"Malik","year":"2007","journal-title":"J Oral Pathol Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1023\/a:1011879900554","article-title":"Biological and clinical relevance of laminin-5 in cancer","volume":"18","author":"Giannelli","year":"2000","journal-title":"Clin Exp Metastasis"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2089","article-title":"Tumour microenvironment: Laminin 332 in squamous-cell carcinoma","volume":"7","author":"Marinkovich","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2009.07.008","article-title":"Defining the role of laminin-332 in carcinoma","volume":"28","author":"Guess","year":"2009","journal-title":"Matrix Biol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4141","article-title":"A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-Kinase activation","volume":"67","author":"Waterman","year":"2007","journal-title":"Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010014","article-title":"The interaction between laminin-332 and Alpha3beta1 integrin determines differentiation and maintenance of cafs, and supports invasion of pancreatic duct adenocarcinoma cells","volume":"11","author":"Cavaco","year":"2018","journal-title":"Cancers"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.09.026","article-title":"Laminin 332 in cancer: When the extracellular matrix turns signals from cell anchorage to cell movement","volume":"62","author":"Rousselle","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1046\/j.1365-2133.1999.02773.x","article-title":"Antiepiligrin (Laminin 5) cicatricial pemphigoid associated with an underlying gastric carcinoma producing laminin 5","volume":"140","author":"Taniuchi","year":"1999","journal-title":"Br J Dermatol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010226","article-title":"Unique biological activity and potential role of monomeric laminin-Gamma2 as a novel biomarker for hepatocellular carcinoma: A review","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/his.13974","article-title":"Ln-gamma 2 chain of laminin-332 is a useful marker in differentiating between benign and malignant sclerosing adnexal neoplasms","volume":"76","author":"Koga","year":"2020","journal-title":"Histopathology"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200007000-00033","article-title":"Remission of antiepiligrin (Laminin-5) cicatricial pemphigoid after excision of gastric carcinoma","volume":"19","author":"Uchiyama","year":"2000","journal-title":"Cornea"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12348","article-title":"Remission of anti-epiligrin cicatricial pemphigoid after excision of cervical adenocarcinoma","volume":"41","author":"Ding","year":"2014","journal-title":"J Cutaneous Pathol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2000.4972","article-title":"In vitro organ culture model for mucous membrane pemphigoid","volume":"98","author":"Colon","year":"2001","journal-title":"Clin Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.8972","article-title":"Ocular cicatricial pemphigoid (Review)","volume":"20","author":"Branisteanu","year":"2020","journal-title":"Exp Ther Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13081140","article-title":"Is the conjunctiva a potential target for advanced therapy medicinal products","volume":"13","author":"Diebold","year":"2021","journal-title":"Pharmaceutics"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118942","article-title":"Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice","volume":"98","author":"Lazarova","year":"1996","journal-title":"J Clin Invest"},{"key":"B96","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1006\/clim.2000.4845","article-title":"Fab fragments directed against laminin 5 induce subepidermal blisters in neonatal mice","volume":"95","author":"Lazarova","year":"2000","journal-title":"Clin Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.03.037","article-title":"Experimental laminin 332 mucous membrane pemphigoid critically involves C5ar1 and reflects clinical and immunopathological characteristics of the human disease","volume":"137","author":"Heppe","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.jid.2021.04.009","article-title":"Dapsone suppresses disease in preclinical murine models of pemphigoid diseases","volume":"141","author":"Murthy","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.865241","article-title":"Cutaneous kinase activity correlates with treatment outcomes following Pi3k delta inhibition in mice with experimental pemphigoid diseases","volume":"13","author":"Ghorbanalipoor","year":"2022","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1099535","article-title":"Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following Pi3k delta inhibition in mice with experimental pemphigoid diseases","volume":"13","author":"Ghorbanalipoor","year":"2022","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.812627","article-title":"Increased fibrosis in a mouse model of anti-laminin 332 mucous membrane pemphigoid remains unaltered by inhibition of aldehyde dehydrogenase","volume":"12","author":"Patzelt","year":"2021","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.87001","article-title":"Aldehyde dehydrogenase inhibition blocks mucosal fibrosis in human and mouse ocular scarring","volume":"1","author":"Ahadome","year":"2016","journal-title":"JCI Insight"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.775412","article-title":"Subunit-specific reactivity of autoantibodies against laminin-332 reveals direct inflammatory mechanisms on keratinocytes","volume":"12","author":"Bao","year":"2021","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14501","article-title":"Gene expression profiling of laminin Alpha3-blocked keratinocytes reveals an immune-independent mechanism of blistering","volume":"31","author":"Bao","year":"2022","journal-title":"Exp Dermatol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15496","article-title":"Human orf complicated by epidermolysis bullosa acquisita","volume":"178","author":"Zuelgaray","year":"2018","journal-title":"Br J Dermatol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15299","article-title":"Post-orf epidermolysis bullosa acquisita","volume":"33","author":"Daneshpazhooh","year":"2019","journal-title":"J Eur Acad Dermatol Venereol: JEADV"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12337073","article-title":"Noncomplement fixing, Igg4 autoantibodies predominate in patients with anti-epiligrin cicatricial pemphigoid","volume":"109","author":"Hsu","year":"1997","journal-title":"J Invest Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1250115\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T22:59:59Z","timestamp":1691708399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1250115\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":107,"alternative-id":["10.3389\/fimmu.2023.1250115"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1250115","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"article-number":"1250115"}}